SM DIAGNOSTICS
NPI 1013930429
Clinical Medical Laboratory in Miami, FL
NPI Status: Active since July 26, 2006
Contact Information
7290 SW 42ND ST
MIAMI, FL
ZIP 33155
Phone: (800) 563-3309
Fax: (800) 833-1066
- Organization
- Clinical Medical Laboratory
- CLIA Number: 10D2262324
- CLIA Cert. Type: Independent
- CLIA Exp. Date: 04-01-2026
About SM DIAGNOSTICS
This page provides the complete NPI Profile along with additional information for Sm Diagnostics, a provider established in Miami, Florida operating as a Clinical Medical Laboratory. The healthcare provider is registered in the NPI registry with number 1013930429 assigned on July 2006. The practitioner's primary taxonomy code is 291U00000X with license number 800001649 (FL). The provider is registered as an organization and their NPI record was last updated 5 years ago. The provider's is doing business as Sm Diagnostics. The authorized official of this NPI record is Mr. Suren Musheyev (Ceo)
- NPI
- 1013930429
- Provider Legal Name
- FLORIDA FAMILY LABORATORY, INC.
- Other Organization Name
- SM DIAGNOSTICS
- Other Name Type
- Doing Business As (3)
- Entity Type
- Organization
- Location Address
- 7290 SW 42ND ST MIAMI, FL 33155
- Location Phone
- (800) 563-3309
- Location Fax
- (800) 833-1066
- Mailing Address
- 7290 SW 42ND ST MIAMI, FL 33155
- Mailing Phone
- (800) 563-3309
- Mailing Fax
- (800) 833-1066
- Is Sole Proprietor?
- No
- Is Organization Subpart?
- No
- Enumeration Date
- 07-26-2006
- Last Update Date
- 10-19-2021
- Code Navigator
Establishments like Sm Diagnostics are healthcare facilities that may perform a wide range of laboratory procedures, assisted by doctors and medical technologists. Laboratories can be categorized according to their function as common diagnostic labs or specialty labs that conduct specialized or confirmatory tests. Different clinical laboratories could specialize in clinical chemistry, clinical microbiology, hematology, serology, clinical microscopy, cytopathology, molecular biology, or public health. Please inquire directly with this provider to confirm their test menu.
Clinical labs in the U.S. that perform human testing are regulated by the Centers for Medicare & Medicaid Services (CMS) through the Clinical Laboratory Improvement Amendments (CLIA) program. The purpose of the CLIA program is to guarantee the quality of laboratory testing. This provider has a CLIA number assigned, and undergoes regular inspections to ensure compliance and quality.
Location Map
Specialty - Primary Taxonomy
The NPI enumerator requires providers to submit at least one taxonomy code. A taxonomy code is a unique 10-character code that describes the healthcare provider type, classification, and the area of specialization. There could be only one primary taxonomy code per NPI record. For individual NPIs the license data is associated to the taxonomy code.
- Classification
Clinical Medical Laboratory
- Taxonomy Code
- 291U00000X
- Type
- Laboratories
- License No.
- 800001649
- License State
- FL
- Taxonomy Description
- (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology.
Insurance Plans Accepted
According to publicly available information the provider might be accepting the following health plans from these health insurance companies:
Specific plan information not avaialable, please contact the provider to verify if your insurance plan is accepted.
Specific plan information not avaialable, please contact the provider to verify if your insurance plan is accepted.
*Please verify directly with this provider to make sure your insurance plan is currently accepted.
Additional Identifiers
The NPI Enumerator encourages providers to submit additional identifiers with their NPI application although the submission of this information is optional. The additional identifier(s) section includes other numbers or codes currently or formerly used as an identifier for the provider by other public healthcare entities. The identifiers may include UPIN, NSC, OSCAR, DEA, Medicaid State or PIN identification numbers.
| Identifier | Type / Code | Identifier State | Identifier Issuer |
|---|---|---|---|
| 03007050 | MEDICAID (05) | FL |
Areas of Expertise
The following services and procedures, recently provided to Medicare patients, illustrate the range of care this provider offers. This list reflects the variety of services available to all patients visiting the practice and is based on 2022 Medicare dataset. In general, the more frequently a provider treats specific conditions or performs particular procedures, the more experienced they become in addressing similar patient needs. The provider has delivered many of the services listed below to Medicare patients. Please note that this list does not include services provided to patients who are not covered by Medicare.
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r
Gene analysis (adenomatous polyposis coli), duplication or deletion variants
Gene analysis (adenomatous polyposis coli), full gene sequence
Gene analysis (bloom syndrome, recq helicase-like)
Gene analysis (breast cancer 1 and 2) of full sequence and analysis for duplication or deletion variants
Gene analysis (coagulation factor ix) full sequence analysis
Gene analysis (mutl homolog 1, colon cancer, nonpolyposis type 2) duplication or deletion variants
Gene analysis (mutl homolog 1, colon cancer, nonpolyposis type 2) full sequence analysis
Gene analysis (muts homolog 2, colon cancer, nonpolyposis type 1) duplication or deletion variants
Gene analysis (muts homolog 2, colon cancer, nonpolyposis type 1) full sequence analysis
Gene analysis (muts homolog 6 [e coli]) duplication or deletion variants
Gene analysis (muts homolog 6 [e coli]) full sequence analysis
Gene analysis (partner and localizer of brca2) full sequence analysis
Gene analysis (phosphatase and tensin homolog), duplication or deletion variant
Gene analysis (phosphatase and tensin homolog), full sequence analysis
Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) duplication or deletion variants
Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) full sequence analysis
Gene analysis (tumor protein 53) full sequence analysis
Gene analysis (v-kit hardy-zuckerman 4 feline sarcoma viral oncogene homolog), d816 variants
Gene analysis (v-kit hardy-zuckerman 4 feline sarcoma viral oncogene homolog), targeted sequence
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within
Molecular pathology procedure level 2
Molecular pathology procedure level 4
Molecular pathology procedure level 5
Molecular pathology procedure level 6 genetic analysis
Test for detecting genes associated with heart disease, duplication/deletion analysis panel
Test for detecting genes associated with heart disease, duplication/deletion analysis panel, at least 2 genes
Test for detecting genes associated with heart disease, genomic sequence analysis panel, at least 10 genes
Test for detecting genes associated with heart disease, genomic sequence analysis panel, at least 9 genes
This service involves the testing for COVID-19 using advanced technologies that can process multiple samples at once. It identifies different types or subtypes of the virus, including SARS-CoV-2/2019-nCoV. This test is non-CDC but adheres to the guidelines outlined in CMS-2020-01-R.
This service was performed 27 times for 17 patientsGene analysis of the adenomatous polyposis coli is a test that detects changes in the APC gene. These changes may cause certain health conditions. Duplication or deletion variants refer to parts of the gene being repeated or missing. This information helps tailor treatment plans.
This service was performed 389 times for 389 patientsGene analysis of the adenomatous polyposis coli (APC) involves studying the entire sequence of the APC gene. This test helps identify mutations that could lead to conditions like familial adenomatous polyposis. The procedure is non-invasive and uses a blood sample.
This service was performed 369 times for 369 patientsGene analysis for Bloom Syndrome involves studying the RECQ helicase-like gene. This gene is responsible for DNA repair. When it's not working properly, it can lead to Bloom Syndrome, a condition that increases the risk of developing various types of cancer.
This service was performed 18 times for 18 patientsGene analysis for breast cancer 1 and 2 involves studying your DNA to detect alterations that may increase your risk of developing certain health issues. This test analyzes the full sequence and checks for duplication or deletion variants.
This service was performed 247 times for 247 patientsGene analysis for coagulation factor IX is a process that examines your genes, specifically the one responsible for factor IX - a protein that helps blood clot. It can detect any changes or mutations in this gene, which could affect your body's ability to control bleeding.
This service was performed 15 times for 15 patientsGene analysis for MLH1 is a test that checks for changes in the MLH1 gene, which if altered, can increase the risk of colon cancer. Duplication or deletion variants refer to extra or missing copies of the gene. This can help in early detection and prevention.
This service was performed 310 times for 310 patientsGene analysis, specifically for MUTL Homolog 1, linked to colon cancer, involves studying your DNA sequence. This helps identify any changes or mutations that might increase your risk of developing colon cancer. It's a preventive measure to manage potential health risks.
This service was performed 307 times for 307 patientsGene analysis for MUTS homolog 2 (colon cancer, nonpolyposis type 1) duplication or deletion variants is a test that looks for changes in a specific gene linked to a higher risk of colon cancer. It helps identify if you carry these gene changes, aiding in early detection and prevention.
This service was performed 309 times for 309 patientsGene analysis (MUTYH) full sequence analysis is a test that examines your DNA to identify any changes linked to nonpolyposis colon cancer type 1. This can help determine your risk of developing this type of cancer.
This service was performed 284 times for 284 patientsGene analysis (muts homolog 6 [e coli]) duplication or deletion variants is a genetic test. It identifies changes in your DNA that could indicate certain health conditions. This test looks specifically at the mutS homolog 6 gene for any duplications or deletions.
This service was performed 303 times for 303 patientsGene analysis, specifically MUTS Homolog 6 (E. coli) full sequence analysis, is a test that examines your DNA to identify changes in the MUTS Homolog 6 gene. This information helps doctors understand and manage potential health concerns.
This service was performed 279 times for 279 patientsGene analysis, specifically for the partner and localizer of BRCA2, involves examining your genetic code to identify any changes in this particular gene. This gene is significant in maintaining the health of your cells. The full sequence analysis means we look at every part of this gene to ensure it's working properly.
This service was performed 407 times for 406 patientsGene analysis for phosphatase and tensin homolog (PTEN) involves studying this specific gene for any duplications or deletions. These changes can impact health and may be associated with certain conditions. This test helps in understanding your genetic makeup better.
This service was performed 394 times for 394 patientsGene analysis, specifically phosphatase and tensin homolog (PTEN) full sequence analysis, is a test that looks at your DNA to identify any changes in the PTEN gene. This gene helps control cell growth and division. Changes may lead to certain health conditions.
This service was performed 396 times for 396 patientsGene analysis for PMS2 duplication or deletion variants involves studying your DNA to detect changes in the PMS2 gene. This gene is important for DNA repair. Variations in this gene could potentially lead to certain health conditions. This test helps to identify these changes early.
This service was performed 303 times for 303 patientsGene analysis, specifically postmeiotic segregation increased 2 (s cerevisiae) full sequence analysis, is a scientific procedure. It involves studying your entire genetic code to identify any changes or differences that could be related to certain health conditions. This is done in a lab, using a sample provided by you.
This service was performed 283 times for 283 patientsGene analysis, specifically tumor protein 53 (TP53) full sequence analysis, is a test that examines the entire TP53 gene. This gene plays a key role in preventing cancer. If there are changes or mutations in this gene, it could lead to an increased risk of developing various types of cancer.
This service was performed 404 times for 403 patientsGene analysis of the V-KIT Hardy-Zuckerman 4 Feline Sarcoma Viral Oncogene Homolog, D816 variants, is a test performed on your DNA. This test helps identify changes or mutations in the KIT gene, which can be associated with certain health conditions.
This service was performed 303 times for 303 patientsGene analysis of v-kit hardy-zuckerman 4 feline sarcoma viral oncogene homolog (KIT) is a test that studies a specific gene associated with cell growth and development. It helps in identifying any alterations in this gene that may lead to health issues.
This service was performed 30 times for 30 patientsThis is a test to detect the COVID-19 virus. It uses a technique that amplifies the virus's genetic material (DNA or RNA) for detection. High throughput technologies are used for rapid and large-scale testing. The procedure is completed within a set time frame.
This service was performed 27 times for 17 patientsA Molecular Pathology Procedure Level 2 is a laboratory test used to study genes at a molecular level. This helps identify genetic variations or mutations that may be associated with certain diseases or conditions. This information assists in diagnosing and managing your healthcare.
This service was performed 12 times for 12 patientsA Molecular Pathology Procedure Level 4 is a sophisticated lab test that analyzes your DNA. It helps identify specific genetic changes that may be causing or increasing the risk of certain diseases. This understanding can aid in diagnosis, treatment, and prevention strategies.
This service was performed 86 times for 79 patientsA Molecular Pathology Procedure Level 5 is a complex lab test that studies genes and proteins at a molecular level. It helps identify genetic changes or infections that may cause or influence disease. This information is crucial for diagnosis and treatment planning.
This service was performed 151 times for 82 patientsA molecular pathology procedure level 6 genetic analysis is a complex lab test. It examines your DNA to identify specific genetic changes that can cause or increase the risk of disease. Understanding these changes can help in tailoring treatments.
This service was performed 104 times for 82 patientsThis test identifies genetic markers linked to heart disease. The duplication/deletion analysis panel scans your DNA for changes that may increase your risk. Understanding your genetic profile can help manage potential heart health risks.
This service was performed 51 times for 51 patientsThis test checks your DNA for changes in at least 2 genes linked to heart disease. It helps identify if you have a higher risk of developing heart conditions. The duplication/deletion analysis looks for extra or missing pieces in these genes.
This service was performed 51 times for 51 patientsThis test identifies genetic variations linked to heart disease. It involves analyzing a panel of 10 genes. Genetic material is extracted from a blood sample and examined for changes that could indicate a higher risk of developing heart conditions.
This service was performed 51 times for 51 patientsThis test analyzes at least 9 specific genes associated with heart disease. It uses a method called genomic sequencing to identify potential genetic risks. Understanding these risks can help in managing heart health more effectively.
This service was performed 55 times for 55 patientsCLIA Information
The Clinical Laboratory Improvement Amendments (CLIA) of 1988 applies to facilities or sites that test human specimens for health assessment or to diagnose, prevent, or treat disease. The CLIA Program sets standards for clinical laboratory testing and issues certificates. The NPI / CLIA crosswalk information for this NPI number is:
- CLIA Number
- 10D2262324
- Facility Type
- Independent
- Certificate Effective Date
- April 02, 2024
- Certificate Expiration Date
- April 01, 2026
- Laboratory Director
- DR. UZMA FAROOQ
- Certificate Type
- Certificate of Accreditation
- Certificate Type Description
- This is a CLIA certificate is issued to Sm Diagnostics on the basis of the laboratory's accreditation by an accreditation organization approved by CMS. This type of certificate is issued to a laboratories tha perform nonwaived (moderate and/or high complexity) testing.
Reviews for SM DIAGNOSTICS
There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.
NPI NPI Number Validation
How NPI Validation Works
The NPI validation process uses the ISO-standard Luhn algorithm, a mathematical "handshake", to ensure that a provider's 10-digit ID is authentic and free of common typing errors.
To verify the NPI 1013930429, we treat the final digit (9) as the Check Digit—the target answer we need to reach. The process begins by taking the first nine digits and adding a constant value of 24, which accounts for the "80840" prefix required for all U.S. health identifiers. We then double every other digit starting from the right and sum the individual digits of those results together. For this specific NPI, that total comes to 51. The final step is to find the difference between that total and the next multiple of ten (60 - 51 = 9).
Digit-by-digit view
Use the first nine digits for the calculation. Starting from the right, double every other digit. The last digit is the check digit and is not part of the calculation.
Step 1: Double every other digit from the right
Starting with the rightmost digit of the first nine digits, double every other value. If doubling creates a two-digit number, add those digits together.
Step 2: Add all digits plus the NPI constant
Add the transformed values, the unchanged digits, and the constant 24.
Step 3: Find the amount needed to reach the next multiple of 10
The next multiple of ten after 51 is 60. The difference is the calculated check digit.
Other Providers at the Same Location
The following 1 provider is registered at the same or a nearby location.
Frequently Asked Questions
The NPI number assigned to this healthcare provider is 1013930429, enumerated as an "organization" on July 26, 2006.
The provider is located at 7290 SW 42ND ST MIAMI, FL 33155 and the phone number is (800) 563-3309.
Clinical Medical Laboratory with taxonomy code 291U00000X.
The provider might be accepting Accepts: Medicare and Medicaid. Please consult your insurance carrier or call the provider to verify.